Human mast cell and airway smooth muscle cell interactions: Implications for asthma

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 281, Issue 6 25-6, 2001, Pages

  Page, Severine ^a   Ammit, Alaina J ^a   Black, Judith L ^b   Armour, Carol L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

Contraction; Cytokines; Inflammation; Proliferation; Remodeling

Indexed keywords

BRADYKININ B2 RECEPTOR; CHEMOKINE; CYTOKINE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; HISTAMINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEUKEMIA INHIBITORY FACTOR; LEUKOTRIENE; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN; RANTES; STEM CELL FACTOR; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; BREATHING MUSCLE; BRONCHOSPASM; BRONCHUS REACTIVITY; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER;

EID: 0035217668     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.281.6.l1313     Document Type: Review

References (147)

1. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi
2. Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells. Modulation by cyclic adenosine monophosphate
3. Activation of the TNFα-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells
4. Induction of human airway hyperresponsiveness by tumour necrosis factor-a
5. Characterization of contractile prostanoid receptors on human airway smooth muscle
6. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
7. The CD 40 antigen and its ligand
8. PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells
9. Worldwide variation in the prevalence of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
10. Cellular events in the bronchi in mild asthma and after bronchial provocation
11. c-kit ligand: A unique potentiator of mediator release by human lung mast cells
12. Monocyte chemotactic protein 1 is a potent activator of human basophils
13. Stem cell factor-dependent survival, proliferation and enhanced releasability of purified mature mast cells isolated from human intestinal tissue
14. Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: Pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects
15. A comparison of the contractile activity of PGD2 and PGF2 alpha on human isolated bronchus
16. Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L
17. Human mast cell cytokines
18. Interleukin-4, -5, -6 and tumor necrosis factor-α in normal and asthmatic airway: Evidence for the human mast cell as a source of these cytokines
19. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains
20. Transforming growth factor β 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis
21. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
22. Cytokines in symptomatic asthma airways
23. Stem cell factor and hematopoiesis
24. Tryptase-induced mitogenesis in airway smooth muscle cells: Potency, mechanisms, and interactions with other mast cell mediators
25. Attenuation of allergic airway inflammation in IL-4 deficient mice
26. Expression of IgE and the high-affinity receptor for IgE (FcεRI) by bronchial epithelial cells of asthmatics
27. Stem cell factor-induced airway hyperreactivity in allergic and normal mice
28. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
29. Mast cell degranulation is related to severity and varies in different airway wall components in asthma
30. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma
31. Airway smooth muscle cells: Contributing to and regulating airway mucosal inflammation?
32. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNFα: Effects of IL-10 and corticosteroids
33. Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors
34. TGF-β 1 modulates human airway smooth muscle cell proliferation induced by mitogens
35. IGFBP-3 mediates TGF-β1-induced cell growth in human airway smooth muscle cells
36. Stem cell factor is localized in, released from, and cleaved by human mast cells
37. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls
38. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, downregulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells
39. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: A 3-D morphometric study
40. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines
41. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium
42. Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9α, 11β-PGF2 and PGFα
43. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma
44. Specific inhibition of β-tryptase in a human mast cell line by granulocyte-macrophage colony-stimulating factor produced by airways structural cells
45. 2 release in human airway smooth muscle cells
46. Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells
47. Mast cells and basophils
48. Human eotaxin is an eosinophil selective chemoattractant that provides a new mechanism to explain tissue eosinophilia
49. Induction of human IgE synthesis in B cells by mast cells and basophils
50. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells
51. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma
52. High-affinity IgE receptor on eosinophils is involved in defence against parasites
53. Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1)
54. Cultured human airway smooth muscle cells stimulated with IL-1β enhance eosinophil survival
55. Epidemiology of asthma: The year in review
56. Transforming growth factor-β1 induces phenotypic modulation of human lung fibroblasts through a c-JunNH2-terminal kinase-dependent pathway
57. Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture
58. Hyperplasia of bronchial muscle in asthma
59. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions
60. Mast cell heterogeneity
61. Reverse distribution of human mast cell subsets in cystic fibrosis
62. Activation of mast cells for mediator release through IgE receptors
63. Interleukin-10 is localized to and released by human lung mast cells
64. The mechanics of airway narrowing in asthma
65. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity
66. Expression and release of interleukin-8 by human airway smooth muscle cells: Inhibition by Th2 cytokines and corticosteroids
67. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines. Regulation by T helper 2 cytokines and corticosteroids
68. Mast cell tryptase potentiates histamine-induced contraction in human sensitised bronchus
69. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways
70. 2 inhibit DNA synthesis in human airway smooth muscle cells in culture
71. Airway smooth muscle cell proliferation is increased in asthma
72. Synthetic functions of airway smooth muscle in asthma
73. Cord blood-derived mast cells produce transforming growth factor β1
74. Production of fibrogenic cytokines by cord blood-derived cultured human mast cells
75. Human bronchial smooth muscle cells in culture produce stem cell factor
76. + cord blood cells
77. Airway remodelling in asthma: Role of airway smooth muscle
78. Production of IL-13 by human lung mast cells
79. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model
80. Airway basophil and mast cell density in patients with bronchial asthma: Relationship to bronchial hyperresponsiveness
81. Mast cells modulate allergic pulmonary eosinophilia in mice
82. Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung
83. CD40-mediated signal transduction in human airway smooth muscle
84. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE
85. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand
86. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells
87. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin
88. Generation of leukotrienes by purified human lung mast cells
89. Mast cell activation enhances airway hyperresponsiveness to methacholine in the mouse
90. Mast cell activation enhances airway responsiveness to methacholine in the mouse
91. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk
92. Tumor necrosis factor-α enhances mRNA expression and secretion of IL-6 in cultures human airway smooth muscle cells
93. The mast cell
94. IL-11 expression is increased in severe asthma: Association with epithelial cells and eosinophils
95. Intercellular adhesion molecule-1 (ICAM-1) and endothelial leukocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic patients
96. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis
97. Pediatric asthma epidemiology: Incidence, morbidity, and mortality
98. Stem cell factor is chemotactic for human mast cells
99. Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells
100. Experimental pulmonary eosinophilia in mice by Ascaris suum extract
101. IgE-anti-IgE-induced prostaglandin D2 release from cultured human mast cells
102. Human lung mast cells are enriched in the capacity to produce granulocytemacrophage colony-stimulating factor in response to IgE-dependent stimulation
103. SCF-induced airway hyperreactivity is dependent on leukotriene production
104. On the role of PGD2 metabolites as markers of mast cell activation in asthma
105. Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNFα-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion
106. Effects of LTD4 on human airway smooth muscle cells proliferation, matrix expression, and contraction in vitro: Differential sensitivity to cysteinyl leukotriene receptor antagonists
107. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression
108. Effect of interleukin-1β, tumour necrosis factor-α and interferon-γ on the induction of cyclooxygenase-2 in cultured human airway smooth muscle cells
109. Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: Role of cyclooxygenase products
110. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways
111. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate
112. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects
113. The pharmacologic control of mediator release from human basophils and mast cells
114. Lung epithelial H292 cells induce differentiation of immature human HMC-1 mast cells by interleukin-6 and stem cell factor
115. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth muscle cells. Modulation by corticosteroids and T-helper 2 cytokines
116. 4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells
117. Does the mast cell still have a key role in asthma?
118. RANTES and macrophage inflammatory protein-Ia induce the migration and activation of normal human eosinophil granulocytes
119. Characterization of cord-blood-derived human mast cells cultured in the presence of Steel factor and interleukin-6
120. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells
121. Release of GM-CSF by human cultured airway smooth muscle cells: Suppression by dexamethasone
122. Selective attraction of monocytes and T lymphocytes of the memory phenotype of cytokine RANTES
123. Characterization of inflammatory mediator release from purified human lung mast cells
124. Interleukin-1β induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells
125. Structure and function of the chemical mediators of mast cells
126. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells
127. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis
128. TNFα modulates mitogenic responses of human cultured airway smooth muscle
129. Cytokines involved in B-cell differentiation and their sites of action
130. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice
131. Microspectrophotometric detection of heparin in young and adult rat mast cells, human mast cells and human basophilic granulocytes stained metachromatically with toluidine blue O
132. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation
133. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules
134. Dendritic cells in normal and asthmatic airways: Expression of the α subunit of the high affinity immunoglobulin E receptor (FcεRIα)
135. Recombinant stem cell factor-induced mast cell activation and smooth muscle contraction in human bronchi
136. Further characterisation of surface membrane structures expressed on human basophils and mast cells
137. Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth muscle cells
138. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial reactivity
139. Anaphylaxis
140. Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells
141. Human leukaemic (HMC-1) and normal skin mast cells express β2-integrins: Characterization of β2-integrins and ICAM-1 on HMC-1 cells
142. Roles of mast cells and basophils in innate and acquired immunity
143. GM-CSF downregulates expression of tryptase, FcεRI and histamine in HMC-1 mast cells
144. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
145. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice
146. Evidence for the increase in asthma worldwide
147. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells